Author

Iris Lansdorp-Vogelaar

Delay in CRC prevention and treatment: The price we pay
Delay in CRC prevention and treatment: The price we pay

Iris Lansdorp-Vogelaar

RISK STRATIFICATION IN COLORECTAL CANCER SCREENING: INTERVAL CANCER RISK AFTER THE UPPER AGE LIMIT OF SCREENING HAS BEEN REACHED
RISK STRATIFICATION IN COLORECTAL CANCER SCREENING: INTERVAL CANCER RISK AFTER THE UPPER AGE LIMIT OF SCREENING HAS BEEN REACHED

Iris Lansdorp-Vogelaar  et al.

THE NATURAL DISEASE COURSE OF THE DEVELOPMENT OF PANCREATIC DUCTAL ADENOCARCINOMA: RESULTS OF A MICROSIMULATION MODEL
THE NATURAL DISEASE COURSE OF THE DEVELOPMENT OF PANCREATIC DUCTAL ADENOCARCINOMA: RESULTS OF A MICROSIMULATION MODEL

Iris Lansdorp-Vogelaar  et al.

A MODEL BASED ANALYSIS ON THE MAXIMUM EFFECT OF PANCREATIC CYST SURVEILLANCE
A MODEL BASED ANALYSIS ON THE MAXIMUM EFFECT OF PANCREATIC CYST SURVEILLANCE

Iris Lansdorp-Vogelaar  et al.

COST-EFFECTIVENESS OF PERSONALIZED SCREENING FOR COLORECTAL CANCER BASED ON PRIOR HEMOGLOBIN LEVELS
COST-EFFECTIVENESS OF PERSONALIZED SCREENING FOR COLORECTAL CANCER BASED ON PRIOR HEMOGLOBIN LEVELS

Iris Lansdorp-Vogelaar  et al.

HIGH RISK FOR UNRELATED MORTALITY AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA IN A NATIONWIDE COHORT OF 1154 PATIENTS
HIGH RISK FOR UNRELATED MORTALITY AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA IN A NATIONWIDE COHORT OF 1154 PATIENTS

Iris Lansdorp-Vogelaar  et al.

DIFFERENCES IN TREATMENT OF STAGE I CRCS: A POPULATION-BASED STUDY OF CRCS DETECTED WITHIN AND OUTSIDE SCREENING
DIFFERENCES IN TREATMENT OF STAGE I CRCS: A POPULATION-BASED STUDY OF CRCS DETECTED WITHIN AND OUTSIDE SCREENING

Iris Lansdorp-Vogelaar  et al.

IMPACT OF FECAL IMMUNOCHEMICAL TEST SCREENING ON COLORECTAL CANCER INCIDENCE AND MORTALITY
IMPACT OF FECAL IMMUNOCHEMICAL TEST SCREENING ON COLORECTAL CANCER INCIDENCE AND MORTALITY

Iris Lansdorp-Vogelaar  et al.

PREDICTION OF MORTALITY CAUSED BY OTHER CAUSES THAN ESOPHAGEAL ADENOCARCINOMA AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA USING THE CHARLSON COMORBIDITY INDEX
PREDICTION OF MORTALITY CAUSED BY OTHER CAUSES THAN ESOPHAGEAL ADENOCARCINOMA AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA USING THE CHARLSON COMORBIDITY INDEX

Iris Lansdorp-Vogelaar  et al.

DIAGNOSTIC YIELD USING A FIT-BASED RISK MODEL WAS NOT BETTER THAN FIT ONLY: A RANDOMIZED CONTROLLED TRIAL IN THE SECOND ROUND OF THE DUTCH COLORECTAL CANCER SCREENING PROGRAMME
DIAGNOSTIC YIELD USING A FIT-BASED RISK MODEL WAS NOT BETTER THAN FIT ONLY: A RANDOMIZED CONTROLLED TRIAL IN THE SECOND ROUND OF THE DUTCH COLORECTAL CANCER SCREENING PROGRAMME

Iris Lansdorp-Vogelaar  et al.

EFFECTS OF HEALTH INSURANCE COVERAGE GAINS FOR UNINSURED INDIVIDUALS ON COLORECTAL CANCER OUTCOMES IN THE US
EFFECTS OF HEALTH INSURANCE COVERAGE GAINS FOR UNINSURED INDIVIDUALS ON COLORECTAL CANCER OUTCOMES IN THE US

Iris Lansdorp-Vogelaar  et al.

RISK PREDICTION FOR ADVANCED NEOPLASIA USING LONGITUDINAL ADHERENCE MEASURES TO FECAL IMMUNOCHEMICAL TEST-BASED COLORECTAL CANCER SCREENING PROGRAMS
RISK PREDICTION FOR ADVANCED NEOPLASIA USING LONGITUDINAL ADHERENCE MEASURES TO FECAL IMMUNOCHEMICAL TEST-BASED COLORECTAL CANCER SCREENING PROGRAMS

Iris Lansdorp-Vogelaar  et al.

STANDARDIZING THE POSITIVE PREDICTIVE VALUE IN A FIT-BASED COLORECTAL CANCER SCREENING PROGRAM
STANDARDIZING THE POSITIVE PREDICTIVE VALUE IN A FIT-BASED COLORECTAL CANCER SCREENING PROGRAM

Iris Lansdorp-Vogelaar  et al.

IMPACT OF DELAYED SCREENING INVITATIONS DUE TO COVID-19 ON OUTCOMES OF THE DUTCH FIT-BASED COLORECTAL CANCER SCREENING PROGRAMME: INDIVIDUAL-LEVEL DATA ANALYSIS
IMPACT OF DELAYED SCREENING INVITATIONS DUE TO COVID-19 ON OUTCOMES OF THE DUTCH FIT-BASED COLORECTAL CANCER SCREENING PROGRAMME: INDIVIDUAL-LEVEL DATA ANALYSIS

Iris Lansdorp-Vogelaar  et al.

THE EFFECTIVENESS OF PERSONALIZED COLORECTAL CANCER SCREENING BASED ON PRIOR FECAL HEMOGLOBIN CONCENTRATION: PERFECT-FIT STUDY PROTOCOL
THE EFFECTIVENESS OF PERSONALIZED COLORECTAL CANCER SCREENING BASED ON PRIOR FECAL HEMOGLOBIN CONCENTRATION: PERFECT-FIT STUDY PROTOCOL

Iris Lansdorp-Vogelaar  et al.

RISK OF INTERVAL COLORECTAL CANCER AFTER NEGATIVE FIT BY QUANTITATIVE FIT-RESULT IN THE DUTCH CRC SCREENING PROGRAM
RISK OF INTERVAL COLORECTAL CANCER AFTER NEGATIVE FIT BY QUANTITATIVE FIT-RESULT IN THE DUTCH CRC SCREENING PROGRAM

Iris Lansdorp-Vogelaar  et al.

NATIONWIDE EVALUATION OF THE DUTCH COLORECTAL CANCER SCREENING PROGRAM
NATIONWIDE EVALUATION OF THE DUTCH COLORECTAL CANCER SCREENING PROGRAM

Iris Lansdorp-Vogelaar  et al.

COST-EFFECTIVENESS OF COLORECTAL CANCER SURVEILLANCE IN HODGKIN LYMPHOMA SURVIVORS
COST-EFFECTIVENESS OF COLORECTAL CANCER SURVEILLANCE IN HODGKIN LYMPHOMA SURVIVORS

Iris Lansdorp-Vogelaar  et al.

PRECURSOR PREVALENCE INDUCES THE INCIDENCE OF GASTRIC CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS
PRECURSOR PREVALENCE INDUCES THE INCIDENCE OF GASTRIC CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS

Iris Lansdorp-Vogelaar  et al.

PREVALENCE OF NEOPLASIA AT COLONOSCOPY AMONG TESTICULAR CANCER SURVIVORS TREATED WITH PLATINUM-BASED CHEMOTHERAPY
PREVALENCE OF NEOPLASIA AT COLONOSCOPY AMONG TESTICULAR CANCER SURVIVORS TREATED WITH PLATINUM-BASED CHEMOTHERAPY

Iris Lansdorp-Vogelaar  et al.

Item 1 - 20 / 20
1